Consequently, targeting YAP/TEAD transcriptional activity could be a promising new way to inhibit pathological effect induced by TNF, and probably by other cytokines, on cell phenotype in human inflammatory-associated diseases such as cancer and chronic inflammatory disorders. The gene discussed is TNF; the disease is cancer.